BioCardia, Inc. (BCDA) income statement
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.02 (-2.06%)
Close on Nov 18, 2026Market cap $11.69MP/E –Yield –
BioCardia, Inc. financial ratios
See a number that looks wrong?